378 related articles for article (PubMed ID: 11511288)
21. The progression of myopia from its onset at age 8-12 to adulthood and the influence of heredity and external factors on myopic progression. A 23-year follow-up study.
Pärssinen O; Kauppinen M; Viljanen A
Acta Ophthalmol; 2014 Dec; 92(8):730-9. PubMed ID: 24674576
[TBL] [Abstract][Full Text] [Related]
22. A randomized clinical trial of bifocal glasses for myopic children with esophoria: results after 54 months.
Fulk GW; Cyert LA; Parker DE
Optometry; 2002 Aug; 73(8):470-6. PubMed ID: 12365670
[TBL] [Abstract][Full Text] [Related]
23. The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren.
Wu PC; Yang YH; Fang PC
J Ocul Pharmacol Ther; 2011 Oct; 27(5):461-6. PubMed ID: 21815829
[TBL] [Abstract][Full Text] [Related]
24. In focus: the use of bifocal spectacles with children with Down's syndrome.
Stewart RE; Margaret Woodhouse J; Trojanowska LD
Ophthalmic Physiol Opt; 2005 Nov; 25(6):514-22. PubMed ID: 16343127
[TBL] [Abstract][Full Text] [Related]
25. Effect of topical atropine on astigmatism.
Chia A; Chua WH; Tan D
Br J Ophthalmol; 2009 Jun; 93(6):799-802. PubMed ID: 19211603
[TBL] [Abstract][Full Text] [Related]
26. Further observations on use of atropine in the treatment of myopia.
Brenner RL
Ann Ophthalmol; 1985 Feb; 17(2):137-40. PubMed ID: 3994212
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes of photorefractive keratectomy for anisometropic amblyopia in children.
Paysse EA; Coats DK; Hussein MA; Hamill MB; Koch DD
Ophthalmology; 2006 Feb; 113(2):169-76. PubMed ID: 16360207
[TBL] [Abstract][Full Text] [Related]
28. Effects of different concentrations of atropine on controlling myopia in myopic children.
Shih YF; Chen CH; Chou AC; Ho TC; Lin LL; Hung PT
J Ocul Pharmacol Ther; 1999 Feb; 15(1):85-90. PubMed ID: 10048351
[TBL] [Abstract][Full Text] [Related]
29. Houston Myopia Control Study: a randomized clinical trial. Part II. Final report by the patient care team.
Grosvenor T; Perrigin DM; Perrigin J; Maslovitz B
Am J Optom Physiol Opt; 1987 Jul; 64(7):482-98. PubMed ID: 3307440
[TBL] [Abstract][Full Text] [Related]
30. The Adolescent and Child Health Initiative to Encourage Vision Empowerment (ACHIEVE) study design and baseline data.
Walline JJ; Jones LA; Chitkara M; Coffey B; Jackson JM; Manny RE; Rah MJ; Prinstein MJ; Zadnik K
Optom Vis Sci; 2006 Jan; 83(1):37-45. PubMed ID: 16432471
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for progressive myopia in the atropine therapy for myopia study.
Loh KL; Lu Q; Tan D; Chia A
Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
[TBL] [Abstract][Full Text] [Related]
32. A report of two more supporters of the medical management of myopia with topical atropine eyedrops and photochromic bifocals.
Pollard ZF
Binocul Vis Strabismus Q; 2002; 17(3):177. PubMed ID: 12171586
[No Abstract] [Full Text] [Related]
33. Multifocal electroretinogram in children on atropine treatment for myopia.
Luu CD; Lau AM; Koh AH; Tan D
Br J Ophthalmol; 2005 Feb; 89(2):151-3. PubMed ID: 15665343
[TBL] [Abstract][Full Text] [Related]
34. The Hong Kong progressive lens myopia control study: study design and main findings.
Edwards MH; Li RW; Lam CS; Lew JK; Yu BS
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2852-8. PubMed ID: 12202502
[TBL] [Abstract][Full Text] [Related]
35. Current status on the development and treatment of myopia.
Cooper J; Schulman E; Jamal N
Optometry; 2012 May; 83(5):179-99. PubMed ID: 23249121
[TBL] [Abstract][Full Text] [Related]
36. The Houston myopia control study: a preliminary report by the patient care team.
Grosvenor T; Maslovitz B; Perrigin DM; Perrigin J
J Am Optom Assoc; 1985 Aug; 56(8):636-43. PubMed ID: 3897351
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of 0.5% atropine in controlling high myopia in children.
Chou AC; Shih YF; Ho TC; Lin LL
J Ocul Pharmacol Ther; 1997 Feb; 13(1):61-7. PubMed ID: 9029440
[TBL] [Abstract][Full Text] [Related]
38. The treatment of myopia with atropine and bifocals. A long-term prospective study.
Brodstein RS; Brodstein DE; Olson RJ; Hunt SC; Williams RR
Ophthalmology; 1984 Nov; 91(11):1373-9. PubMed ID: 6514306
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with spectacle-wear compliance in school-aged Mexican children.
Castanon Holguin AM; Congdon N; Patel N; Ratcliffe A; Esteso P; Toledo Flores S; Gilbert D; Pereyra Rito MA; Munoz B
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):925-8. PubMed ID: 16505025
[TBL] [Abstract][Full Text] [Related]
40. Contrast sensitivity of wildtype mice wearing diffusers or spectacle lenses, and the effect of atropine.
Schmucker C; Schaeffel F
Vision Res; 2006 Mar; 46(5):678-87. PubMed ID: 15993919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
